2OGZ | pdb_00002ogz

Crystal structure of DPP-IV complexed with Lilly aryl ketone inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.10 Å
  • R-Value Free: 
    0.268 (Depositor), 0.261 (DCC) 
  • R-Value Work: 
    0.233 (Depositor), 0.225 (DCC) 
  • R-Value Observed: 
    0.233 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 2OGZ

Ligand Structure Quality Assessment 


This is version 1.5 of the entry. See complete history

Literature

Discovery of non-covalent dipeptidyl peptidase IV inhibitors which induce a conformational change in the active site.

Sheehan, S.M.Mest, H.J.Watson, B.M.Klimkowski, V.J.Timm, D.E.Cauvin, A.Parsons, S.H.Shi, Q.Canada, E.J.Wiley, M.R.Ruehter, G.Evers, B.Petersen, S.Blaszczak, L.C.Pulley, S.R.Margolis, B.J.Wishart, G.N.Renson, B.Hankotius, D.Mohr, M.Zechel, J.C.Michael Kalbfleisch, J.Dingess-Hammond, E.A.Boelke, A.Weichert, A.G.

(2007) Bioorg Med Chem Lett 17: 1765-1768

  • DOI: https://doi.org/10.1016/j.bmcl.2006.12.074
  • Primary Citation Related Structures: 
    2OGZ

  • PubMed Abstract: 

    A series of non-covalent inhibitors of the serine protease dipeptidyl peptidase IV (DPP-IV) were found to adopt a U-shaped binding conformation in X-ray co-crystallization studies. Remarkably, Tyr547 undergoes a 70 degrees side-chain rotation to accommodate the inhibitor and allows access to a previously unexposed area of the protein backbone for hydrogen bonding.


  • Organizational Affiliation
    • Lilly Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, IN 46285, USA. SHEEHAN_SCOTT@LILLY.COM

Macromolecule Content 

  • Total Structure Weight: 169.58 kDa 
  • Atom Count: 12,514 
  • Modeled Residue Count: 1,454 
  • Deposited Residue Count: 1,456 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Dipeptidyl peptidase
A, B
728Homo sapiensMutation(s): 0 
Gene Names: DPP4ADCP2CD26
EC: 3.4.14.5
UniProt & NIH Common Fund Data Resources
Find proteins for P27487 (Homo sapiens)
Explore P27487 
Go to UniProtKB:  P27487
PHAROS:  P27487
GTEx:  ENSG00000197635 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP27487
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
U1N

Query on U1N



Download:Ideal Coordinates CCD File
C [auth A],
D [auth B]
4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE
C19 H21 F N2 O2
OIWWNWQZJJKBTR-CYBMUJFWSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.10 Å
  • R-Value Free:  0.268 (Depositor), 0.261 (DCC) 
  • R-Value Work:  0.233 (Depositor), 0.225 (DCC) 
  • R-Value Observed: 0.233 (Depositor) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 63.595α = 90
b = 122.304β = 100.2
c = 112.721γ = 90
Software Package:
Software NamePurpose
DENZOdata reduction
SCALEPACKdata scaling
AMoREphasing
CNSrefinement
PDB_EXTRACTdata extraction
MAR345data collection
HKL-2000data reduction
HKL-2000data scaling

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

  • Released Date: 2007-03-06 
  • Deposition Author(s): Timm, D.E.

Revision History  (Full details and data files)

  • Version 1.0: 2007-03-06
    Type: Initial release
  • Version 1.1: 2008-05-01
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance
  • Version 1.3: 2017-10-18
    Changes: Refinement description
  • Version 1.4: 2023-08-30
    Changes: Data collection, Database references, Derived calculations, Refinement description
  • Version 1.5: 2024-10-30
    Changes: Structure summary